Apr 24, 6:39 AM EDT
Everything You Need To Know, Right Now.
Stay connected to the biggest stories unfolding in technology.
The IBTech Newsletter keeps you connected to the biggest stories unfolding in technology.
Please enter a valid email
Media & Culture
Alexion Pharma Q3 loss narrows on robust Soliris sales
By IBT Staff Reporter on 10/25/07 AT 11:00 AM
Alexion Pharmaceuticals Inc posted a narrower third-quarter loss, helped by sales of its key drug Soliris, sending its shares up nearly 8 percent in early electronic trade.